MeSH | Streptococcal Infections (D013290)

Streptococcal Infections D013290

Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Bacterial Infections » Gram-Positive Bacterial Infections » Streptococcal Infections

Description

Infections with bacteria of the genus STREPTOCOCCUS. MeSH

Hierarchy View

View MeSH Tree

Subtype Terms (7)

Ecthyma
2 approved drugs

Endocarditis, Subacute Bacterial

Erysipelas
4 drugs (3 approved, 1 experimental)

Impetigo
15 drugs (10 approved, 5 experimental)

Pneumococcal Infections
65 drugs (35 approved, 30 experimental)

Rheumatic Fever
11 drugs (5 approved, 6 experimental)

Scarlet Fever
2 approved drugs

Approved Indicated Drugs (2)

lincomycin (lincocin)

phenoxymethylpenicillin

Phase 4 Indicated Drugs (12)

acetaminophen (tylenol)

albumin (Human) (Plasbumin)

cefuroxime (zinacef)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix)

DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine (Pediarix)

haemophilus influenzae type b conjugate vaccine (HibTITER)

ibuprofen (motrin)

immune globulin (human) (Gamastan)

Inactivated polio virus - Enhanced (IPOL)

pneumococcal 7-valent conjugate vaccine (Prevnar)

procaine benzylpenicillin (novocaine)

Phase 3 Indicated Drugs (14)

10-valent Pneumococcal Conjugate Vaccine (Pneumosil)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23)

attenuated measles vaccine - Edmonston strain (rubeovax)

diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine

hepatitis a vaccine, inactivated (vaqta)

hepatitis b vaccine (recombinant) (Recombivax)

human rotavirus, live attenuated (Rotarix)

live oral poliovirus type 1, 2 and 3 (Trivalent oral polio vaccine - Sabin)

meningococcal conjugate vaccine - Menactra (Menactra)

multi-valent pneumococcal conjugate vaccine

pneumococcal 13-valent conjugate vaccine (prevnar 13)

polio, inactivated poliovirus vaccine (Salk Vaccine)

technetium tc-99m pentetate kit (renotec)

Phase 2 Indicated Drugs (17)

acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia)

alprostadil (prostin)

group b streptoccous 6-valent polysaccharide conjugate vaccine

group b streptococcus trivalent vaccine

haemophilus influenzae type b-neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine

Hexavalent anti capsular polysaccharide

hexavalent pneumococcal polysaccharide vaccine

linezolid (zyvox)

multivalent group b streptococcus vaccine

oritavancin (orbactiv)

yellow fever vaccine 17d strain

Phase 1 Indicated Drugs (10)

11-valent pneumococcal vaccine (gsk513026)

aluminum hydroxide (Gaviscon)

gbs glycoconjugate vaccine

gbs iii-tt-mphl

streptococcus pyogenes

Other Experimental Indicated Drugs (11)

benzathine penicillin

casein phosphopeptide amorphous calcium phosphate

cefazolin (ancef)

chlorhexidine (hibitane)

haloperidol (haldol)

lactobacillus delbrueckii

lactobacillus salivarius

sodium fluoride (18F)

Organization Involved with Phase 4 Indications (7)

GlaxoSmithKline

National Cheng Kung University

National Institute of Mental Health (NIMH)

University of Basel

University of Lyon

Organization Involved with Phase 3 Indications (1)

Cornell University

Organization Involved with Phase 2 Indications (24)

Case Western Reserve University

Department of State for Health and Social Welfare, The Gambia

Duke University

European and Developing Countries Clinical Trials Partnership (EDCTP)

Medical Research Council, The Gambia

Melinta Therapeutics

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Child Health and Human Development (NICHD)

National Institutes of Health (NIH)

Regional Hospital Heilig Hart, Tienen, Belgium

Stanford University

The University of Texas, Dallas

Tufts University

University of Alabama, Birmingham

University of Iowa

University of London

University of New Mexico

University of Utah

Wayne State University

Organization Involved with Phase 1 Indications (17)

Basilea Pharmaceutica

Free University of Brussels

Government of China

Griffith University

Johnson and Johnson

Murdoch University

National Health and Medical Research Council, Australia

Nucleus Network Ltd

Telethon Kids Institute

The Peter Doherty Institute

Tianjin Cansino Biotechnology Inc

University of Auckland

University of Melbourne

University of Queensland

University of Tennessee

University of Wollongong

Organization Involved with Other Experimental Indications (11)

Cairo University

China Medical University

Federal University of Rio de Janeiro

Johns Hopkins University

Ryerson University

United States Agency for International Development

University Hospital for Infectious Diseases, Croatia

World Health Organization

Hierarchy Tree View

MeSH

UMLS Data

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.